Possible involvement of vascular cells-related transcription factors in human inflammatory diseases and cancer tissue.
血管细胞相关转录因子可能参与人类炎症性疾病和癌症组织。
基本信息
- 批准号:07670190
- 负责人:
- 金额:$ 1.47万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1995
- 资助国家:日本
- 起止时间:1995 至 1996
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Inflammatory diseases and cancer are representative diseases associated with angiogenesis. We report here possible involvement of transcription factors GATA family in these lesions by in situ hybridization. Specimens were sampled from human inflammatory bowel disease and colon cancer. Fresh tissues selected from representative areas were fixed in 4% paraformaldehyde + 0.5% glutaradehyde for 16 h, dehydrated and embedded in paraffin. Digoxigenin-labeled tRNAs were made by in vitro transcription. For GATA-1, no significant results were obtained because of no differences between results with sense and antisense probes. Positive signals were obtained for GATA-2 and -3, Angiogenesis was most remarkable in ulcer bases and in cancer stroma, where GATA-2 and -3 were negative in endothelial cells. GATA-2 and -3 were positive in endothelial cells of venules situated in the peripheral zone of ulcer bases, where mild inflammatory cells were distributed. In cancer tissue, GATA-2 and -3 were positive in some of venules located along the invasive margin. This area is characterized by moderate degree of immune/inflammatory infiltrate composed of lymphocytes, monocytes/macrophages and neutrophils. T-cells in ulcer bases were positive for GATA-2 and -3, which corresponded to the area of high-degree inflammation. In cancer tissue, some cancer cells and stromal fibroblasts were positive for GATA-2 and -3. These results suggested that GATA family is involved in inflammatory changes in inflammatory diseases and that occurring in cancer tissue as one of host reactions. This study further supports our concept that there are similarities between the host reactions in cancer tissue and inflammatory changes.
炎症性疾病和癌症是血管生成的代表性疾病。我们在这里报告可能参与转录因子GATA家族在这些病变的原位杂交。标本取自人类炎症性肠病和结肠癌。选取代表性地区的新鲜组织,在4%多聚甲醛+ 0.5%戊二醛溶液中固定16 h,脱水后包埋石蜡。通过体外转录制备地高辛标记的trna。对于GATA-1,由于正义探针和反义探针的结果没有差异,所以没有得到显著的结果。GATA-2和-3表达阳性,血管生成在溃疡基底和癌间质中最为显著,内皮细胞中GATA-2和-3表达阴性。GATA-2和-3在溃疡基底外周区小静脉内皮细胞中呈阳性,该区域有轻度炎症细胞分布。在癌组织中,GATA-2和-3在沿浸润边缘的一些小静脉中呈阳性。该区域的特征是由淋巴细胞、单核细胞/巨噬细胞和中性粒细胞组成的中等程度的免疫/炎症浸润。溃疡基底t细胞GATA-2和-3阳性,与高度炎症区相对应。在癌组织中,部分癌细胞和间质成纤维细胞中GATA-2和-3呈阳性。这些结果提示GATA家族作为宿主反应之一参与炎症性疾病的炎症变化和肿瘤组织的炎症变化。本研究进一步支持了我们的观点,即肿瘤组织中的宿主反应与炎症变化之间存在相似性。
项目成果
期刊论文数量(19)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
鈴木幸正ら: "Cell adhesion molecule expression by vascular endothelial cell as an immune/inflammatory reaction in human colon carcinoma." Jpn J Cancer Res. 86. 585-593 (1995)
Yukimasa Suzuki 等人:“血管内皮细胞的细胞粘附分子表达作为人类结肠癌的免疫/炎症反应。”Jpn J Cancer Res 86. 585-593 (1995)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
大谷明夫ら: "Expression of urokinase receptor in various stromal cell populations in human colon cancer : Immunoelectron microscopical analysis." Int J Cancer. 62. 691-696 (1995)
Akio Otani 等人:“人结肠癌中各种基质细胞群中尿激酶受体的表达:免疫电子显微镜分析。Int J Cancer”62. 691-696 (1995)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Yuriko Saiki, et al.: "Immunophenotypical characterization of Ebstein-Barr virus-associated gastric carcinoma : Massive infiltration by proliferating CD8+ T-lymphocytes." Lab Invest. 75. 67-76 (1996)
Yuriko Saiki 等人:“Ebstein-Barr 病毒相关胃癌的免疫表型特征:增殖的 CD8 T 淋巴细胞大规模浸润。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Haruo, Ohtani et al.: "Similarities of in situ mRNA expression between gelatinase a (MMp-2) and type I procollagen in human gastrointestinal carcinoma : comparison with granulationtissue reaction." Jpn J Cancer Res. 86. 833-839 (1995)
Haruo、Ohtani 等人:“人胃肠癌中明胶酶 a (MMp-2) 和 I 型前胶原之间原位 mRNA 表达的相似性:与肉芽组织反应的比较。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Yukimasa Suzuki, et al.: "Cell adhesion molecule expression by vascular endothelial cells as an immune/inflammatory reaction in human colon carcinoma." Jpn J Cancer Res. 86. 585-593 (1995)
Yukimasa Suzuki 等人:“血管内皮细胞表达细胞粘附分子作为人类结肠癌的免疫/炎症反应。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
OHTANI Haruo其他文献
OHTANI Haruo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('OHTANI Haruo', 18)}}的其他基金
Clinicopathological analyses on the blood-borne metastasis in colorectal carcinoma
结直肠癌血源性转移的临床病理分析
- 批准号:
11670164 - 财政年份:1999
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
In situ expression of matrix-degrading enzymes in inflammatory bowel disease
炎症性肠病基质降解酶的原位表达
- 批准号:
09670174 - 财政年份:1997
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of immunosupprative meclauism of Lipocortiut in tuwcr-beurig hestsits expression and action in wan
脂皮质素在 wan 中 tuwcr-beurig hestsits 表达及作用的免疫抑制作用分析
- 批准号:
04807090 - 财政年份:1992
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似海外基金
I-Corps: Translation potential of using machine learning to predict oxaliplatin chemotherapy benefit in early colon cancer
I-Corps:利用机器学习预测奥沙利铂化疗对早期结肠癌疗效的转化潜力
- 批准号:
2425300 - 财政年份:2024
- 资助金额:
$ 1.47万 - 项目类别:
Standard Grant
Targeting cancer stem-like cells and inflammation for colon cancer chemoprevention
针对癌症干细胞样细胞和炎症进行结肠癌化学预防
- 批准号:
10650910 - 财政年份:2023
- 资助金额:
$ 1.47万 - 项目类别:
Bacteria-derived xenobiotics in colon cancer prevention: Link to GPR109A and colonic ketogenesis
细菌源性异生素在结肠癌预防中的作用:与 GPR109A 和结肠生酮的联系
- 批准号:
10737017 - 财政年份:2023
- 资助金额:
$ 1.47万 - 项目类别:
Generation of chimeric antigen receptor T cells using antibodies derived from colon cancer tumor-associated B cells.
使用源自结肠癌肿瘤相关 B 细胞的抗体生成嵌合抗原受体 T 细胞。
- 批准号:
23K15473 - 财政年份:2023
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Enteric Glia is New Biological Target to Block Drug Resistance in Colon Cancer
肠胶质细胞是阻断结肠癌耐药性的新生物靶点
- 批准号:
10659846 - 财政年份:2023
- 资助金额:
$ 1.47万 - 项目类别:
Mechanisms and strategies to rescue suboptimal T cell priming in colon cancer
挽救结肠癌 T 细胞启动不良的机制和策略
- 批准号:
10644249 - 财政年份:2023
- 资助金额:
$ 1.47万 - 项目类别:
Novel Tools for Colon Cancer Detection and Therapy
结肠癌检测和治疗的新工具
- 批准号:
10480318 - 财政年份:2023
- 资助金额:
$ 1.47万 - 项目类别:
FURTHER DEVELOPMENT OF IPSC-BASED VACCINE FOR COLON CANCER PREVENTION
进一步开发基于 IPSC 的结肠癌预防疫苗
- 批准号:
10893658 - 财政年份:2023
- 资助金额:
$ 1.47万 - 项目类别:
Precision medicine tool for informing the treatment of colon cancer in minutes
精准医疗工具可在几分钟内告知结肠癌的治疗
- 批准号:
10054824 - 财政年份:2023
- 资助金额:
$ 1.47万 - 项目类别:
Collaborative R&D
Breeding of rice with increased the content of glucosylceramide, which improves skin barrier function and prevents colon cancer
培育出增加葡萄糖神经酰胺含量的大米,可改善皮肤屏障功能并预防结肠癌
- 批准号:
23K05119 - 财政年份:2023
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)